About Technology Issues FAQ

Links

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.